|
Name |
4-Hydroxyphenylacetamide
|
Molecular Formula | C8H9NO2 | |
IUPAC Name* |
2-(4-hydroxyphenyl)acetamide
|
|
SMILES |
C1=CC(=CC=C1CC(=O)N)O
|
|
InChI |
InChI=1S/C8H9NO2/c9-8(11)5-6-1-3-7(10)4-2-6/h1-4,10H,5H2,(H2,9,11)
|
|
InChIKey |
YBPAYPRLUDCSEY-UHFFFAOYSA-N
|
|
Synonyms |
4-Hydroxyphenylacetamide; 17194-82-0; 2-(4-Hydroxyphenyl)acetamide; p-Hydroxyphenylacetamide; 4-Hydroxybenzeneacetamide; Benzeneacetamide, 4-hydroxy-; p-(Carbamoylmethyl)phenol; (p-Hydroxyphenyl)acetamide; 2-(p-Hydroxyphenyl)acetamide; 4-(Hydroxyphenyl)acetamide; Acetamide, 2-(p-hydroxyphenyl)-; (4-Hydroxyphenyl)acetamide; MFCD00017145; p-Hydroxyphenyl acetamide; 0HY0N4ITN4; CHEMBL447310; NSC-187193; 4-hydroxy phenylacetamide; EINECS 241-235-0; UNII-0HY0N4ITN4; BRN 2085984; 2-(4-Hydroxyphenyl)-ethylamide; P-Hydroxyphenyl-acetamide; P-HYDROXY BENZYLAMIDE; Oprea1_206241; 3-10-00-00434 (Beilstein Handbook Reference); 4-Hydroxyphenylacetamide,(S); SCHEMBL661973; 4-Hydroxyphenylacetamide, 99%; alpha-(p-Hydroxyphenyl)acetamide; DTXSID4066171; YBPAYPRLUDCSEY-UHFFFAOYSA-; HYDROXYPHENYLACETAMIDE, 4-; ZINC157085; BBL012281; BDBM50339587; NSC187193; STL163593; AKOS005716492; AC-6787; CCG-356424; CS-W016314; NSC 187193; PS-4609; s12297; SY001683; DB-043877; FT-0618730; FT-0618731; H0853; EN300-219225; A811367; W-107869; 2-(4-hydroxyphenyl)acetamide;4-Hydroxyphenylacetamide; Q27236794
|
|
CAS | 17194-82-0 | |
PubChem CID | 86986 | |
ChEMBL ID | CHEMBL447310 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 151.16 | ALogp: | 0.1 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 63.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.657 |
Caco-2 Permeability: | -4.583 | MDCK Permeability: | 0.00003270 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.968 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.311 |
30% Bioavailability (F30%): | 0.46 |
Blood-Brain-Barrier Penetration (BBB): | 0.865 | Plasma Protein Binding (PPB): | 46.87% |
Volume Distribution (VD): | 0.668 | Fu: | 64.34% |
CYP1A2-inhibitor: | 0.086 | CYP1A2-substrate: | 0.102 |
CYP2C19-inhibitor: | 0.059 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.04 | CYP2C9-substrate: | 0.763 |
CYP2D6-inhibitor: | 0.034 | CYP2D6-substrate: | 0.491 |
CYP3A4-inhibitor: | 0.021 | CYP3A4-substrate: | 0.234 |
Clearance (CL): | 14.522 | Half-life (T1/2): | 0.634 |
hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.139 |
Drug-inuced Liver Injury (DILI): | 0.583 | AMES Toxicity: | 0.324 |
Rat Oral Acute Toxicity: | 0.047 | Maximum Recommended Daily Dose: | 0.008 |
Skin Sensitization: | 0.361 | Carcinogencity: | 0.564 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.581 |
Respiratory Toxicity: | 0.016 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000006 | 0.714 | D01CRB | 0.585 | ||||
ENC004860 | 0.658 | D0B3QM | 0.558 | ||||
ENC000129 | 0.585 | D0W1RY | 0.525 | ||||
ENC000665 | 0.583 | D0U5QK | 0.463 | ||||
ENC001422 | 0.535 | D03UOT | 0.444 | ||||
ENC000870 | 0.535 | D01UXC | 0.439 | ||||
ENC000350 | 0.526 | D02AQY | 0.417 | ||||
ENC000676 | 0.526 | D0S2BV | 0.412 | ||||
ENC000740 | 0.526 | D02WAB | 0.396 | ||||
ENC002317 | 0.512 | D02HXS | 0.364 |